Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › tigecycline

tigecycline

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of tigecycline

13 trials tracked of tigecycline: 8 in phase 3 or 4 and 3 with published results. The most-cited published study has 31 citations.

13Trials tracked
8Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 5 Phase 3 3 Phase 2 1 Other / NA 4
  1. Phase 4 Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects Completed · 31 cited
  2. Phase 3 A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) Completed · 20 cited
  3. Phase 4 A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection Completed · 12 cited
  4. Phase 4 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Completed
  5. Phase 4 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Completed
  6. Phase 4 Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections Completed
Show 7 more trials
  1. Phase 3 Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. Completed
  2. Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects Completed
  3. Phase 2 Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections Completed
  4. N/A Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment Completed
  5. N/A A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting Completed
  6. N/A Post-Authorization Study Evaluating Safety Of Tigecycline Completed
  7. N/A Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case report of multidrug resistant Myroides odoratimimus infection in a gastric cancer patient
Infectious Disease Sys. Review
Case report of multidrug resistant Myroides odoratimimus infection in a gastric cancer patient Rare bacteria shows resistance to most common antibiotics
This case report describes a single instance of Myroides odoratimimus infection in a patient with gastric cancer.
A single case study reveals a rare urinary infection that resisted 23 out of 24 antibiotics tested in a laboratory setting.
Frontiers Apr 30, 2026
Review of Therapeutic Options for Carbapenem-Resistant Enterobacterales
Drug Pipeline RCT
Review of Therapeutic Options for Carbapenem-Resistant Enterobacterales New Weapons Emerge in the Fight Against Deadly Superbugs
This review summarizes available and emerging therapies for carbapenem-resistant Enterobacterales.
New drug combinations offer hope for patients facing deadly superbugs that resist almost all current antibiotics.
Frontiers Apr 18, 2026
Retrospective cohort study links prior antibiotic exposure and Gram-negative infections to high MDR rates in adult patients with chronic liver disease
Infectious Disease Cohort
Retrospective cohort study links prior antibiotic exposure and Gram-negative infections to high MDR rates in adult patients with chronic liver disease High antibiotic resistance found in infections among chronic liver disease patients in India
This retrospective observational cohort study evaluated 317 adult patients with chronic liver disease and culture-positive bacterial infecti…
In India, nearly 80% of E. coli and K. pneumoniae infections in chronic liver disease patients are resistant to multiple antibiotics.
Frontiers Apr 16, 2026
Retrospective study finds low resistance to key antibiotics in TB patients with UTIs
Infectious Disease Cohort
Retrospective study finds low resistance to key antibiotics in TB patients with UTIs When TB Treatment Hits a Wall: The Hidden Bladder Problem
A retrospective cohort study of 1,151 bacterial strains from tuberculosis patients with urinary tract infections at a single hospital found …
Tuberculosis patients with urinary infections face drug-resistant bacteria, but a five-year hospital review reveals which antibiotics still …
Frontiers Apr 15, 2026
Retrospective cohort study examines MRSA prevalence and resistance patterns in nosocomial bloodstream infections among 96 patients in central China
Primary Care & Family Medicine Cohort
Retrospective cohort study examines MRSA prevalence and resistance patterns in nosocomial bloodstream infections among 96 patients in central China Are hospital infections getting harder to treat, or is the data stable?
This retrospective cohort study analyzed 96 Staphylococcus aureus isolates from patients with nosocomial bloodstream infections at a tertiar…
Hospital bloodstream infections from tough MRSA bacteria stayed stable in frequency, but one patient's germ was resistant to the last-resort…
Frontiers Apr 14, 2026
Tigecycline monotherapy shows no outcome disadvantage versus combination therapy for MDR gram-negative infections in retrospective cohort
Infectious Disease Cohort
Tigecycline monotherapy shows no outcome disadvantage versus combination therapy for MDR gram-negative infections in retrospective cohort Study finds no clear benefit of combination therapy over tigecycline alone for resistant infections
A retrospective cohort study of 280 hospitalized adults with MDR gram-negative infections found no independent association between tigecycli…
Combining antibiotics with tigecycline offers no clear benefit over using the drug alone for treating severe, drug-resistant bacterial infec…
Frontiers Apr 4, 2026